21 studies found for:    Sm-153
Show Display Options
Rank Status Study
1 Completed
Has Results
Samarium-153 With Neoadjuvant Hormonal and Radiation Therapy for Locally Advanced Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Samarium-153;   Drug: Total Androgen Suppression (TAS) with Bicalutamide;   Drug: Total androgen suppression (TAS) with Goserelin Acetate;   Device: Radiation Therapy
2 Active, not recruiting Sm-EDTMP and Autologous Peripheral Blood Stem Cell Transplantation for Breast Cancer Patients With Bone Only Metastases
Conditions: Breast Cancer;   Bone Metastases
Interventions: Drug: 153 Sm-EDTMP;   Behavioral: Questionnaire;   Procedure: Stem Cell Transplant
3 Completed Samarium Sm 153 and Stem Cell Transplant Followed By Radiation Therapy Patients With Osteosarcoma
Condition: Sarcoma
Interventions: Biological: filgrastim;   Drug: ifosfamide;   Procedure: peripheral blood stem cell transplantation;   Radiation: radiation;   Radiation: samarium Sm 153 lexidronam pentasodium
4 Active, not recruiting Samarium Sm 153 Lexidronam Pentasodium and 3-Dimensional Conformal Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Rising Prostate-Specific Antigen Levels After Radical Prostatectomy for Prostate Cancer
Condition: Prostate Cancer
Interventions: Radiation: 3-dimensional conformal radiation therapy (3D-CRT);   Radiation: intensity-modulated radiation therapy (IMRT);   Radiation: samarium Sm 153 lexidronam pentasodium
5 Active, not recruiting Samarium Sm 153 Lexidronam Pentasodium Combined With Zoledronic Acid or Pamidronate in Treating Patients With Relapsed or Refractory Multiple Myeloma and Bone Pain
Conditions: Multiple Myeloma and Plasma Cell Neoplasm;   Pain
Interventions: Drug: Pamidronate;   Drug: Zoledronic acid;   Radiation: Sm 153 lexidronam
6 Recruiting Combination of External Beam Radiotherapy With 153Sm-EDTMP to Treat High Risk Osteosarcoma
Condition: Metastatic Osteosarcoma
Interventions: Drug: 153Sm-EDTMP;   Other: Autologous Peripheral Blood or Bone Marrow Stem Cell Infusion;   Radiation: External Beam Radiotherapy
7 Unknown  Study of Samarium Sm-153 Lexidronam Combined With Docetaxel for Patients With Prostate Cancer
Condition: Prostatic Neoplasms
Intervention: Drug: Samarium Sm-153 lexidronam + Docetaxel
8 Completed Samarium Sm 153 Lexidronam Pentasodium and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Interventions: Drug: bortezomib;   Other: immunologic technique;   Radiation: samarium Sm 153 lexidronam pentasodium
9 Completed Samarium 153 and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Interventions: Drug: bortezomib;   Radiation: samarium Sm 153 lexidronam pentasodium
10 Completed Study of Docetaxel +153 Sm-EDTMP in Patients With Hormone-Refractory Prostate Cancer
Condition: Prostate Cancer
Intervention: Drug: Docetaxel
11 Completed
Has Results
153Sm-EDTMP With or Without a PSA/TRICOM Vaccine To Treat Men With Androgen-Insensitive Prostate Cancer
Condition: Prostate Cancer
Interventions: Radiation: Samarium Sm 153 lexidronam pentasodium;   Biological: Sargramostim;   Biological: Recombinant vaccinia-TRICOM vaccine;   Biological: Recombinant fowlpox-TRICOM vaccine
12 Active, not recruiting Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancer
Conditions: Breast Cancer;   Lung Cancer;   Metastatic Cancer;   Pain;   Prostate Cancer
Interventions: Dietary Supplement: calcium carbonate;   Dietary Supplement: calcium citrate;   Dietary Supplement: calcium glucarate;   Dietary Supplement: vitamin D;   Drug: calcium gluconate;   Drug: zoledronic acid;   Radiation: samarium Sm 153 lexidronam pentasodium;   Radiation: strontium chloride Sr 89
13 Completed Samarium Sm 153 Lexidronam Pentasodium and High-Dose Melphalan in Treating Patients With Multiple Myeloma Undergoing Stem Cell Transplant
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Interventions: Biological: sargramostim;   Drug: melphalan;   Procedure: autologous hematopoietic stem cell transplantation;   Procedure: peripheral blood stem cell transplantation;   Radiation: samarium Sm 153 lexidronam pentasodium
14 Unknown  A Trial of Samarium 153 Followed by Salvage Prostatic Fossa 3D-CRT or IMRT Irradiation in High-Risk, Clinically Non-Metastatic Prostate Cancer After Radical Prostatectomy
Conditions: Non-metastatic Prostate Cancer;   Post Radical Prostatectomy
Interventions: Drug: Samarium/IMRT;   Drug: Samarium ethylenediaminetetramethylenephosphonate
15 Unknown  Repeated Bone Marrow Transplantation in Treating Women With Advanced Breast Cancer
Condition: Breast Cancer
Interventions: Biological: filgrastim;   Drug: CAF regimen;   Drug: carboplatin;   Drug: cisplatin;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: fluorouracil;   Drug: ifosfamide;   Drug: melphalan;   Drug: paclitaxel;   Drug: thiotepa;   Procedure: peripheral blood stem cell transplantation;   Radiation: samarium Sm 153 lexidronam pentasodium
16 Unknown  Effect of Samarium on the Relief of Pain Due to Vertebral Metastases
Conditions: Cancer;   Metastasis;   Pain
Intervention: Drug: Samarium (153SM)
17 Completed A Study of Oral AMN107 in Adults With Chronic Myelogenous Leukemia (CML) or Other Blood Related Cancers
Conditions: Chronic Myelogenous Leukemia;   Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive);   Hypereosinophilic Syndrome;   Systemic Mastocytosis
Intervention: Drug: Nilotinib
18 Suspended Evaluation of the CardioSond Electronic Stethoscope in the Detection of Coronary Artery Disease
Condition: Coronary Artery Disease
Intervention:
19 Completed
Has Results
A Study of Intravenous or Subcutaneous Methoxy Polyethylene Glycol-Epoetin Beta (RO0503821, Mircera) in Chronic Kidney Disease Patients With Renal Anemia
Condition: Anemia
Interventions: Drug: Methoxy Polyethylene Glycol-Epoetin Beta;   Drug: Epoetin alfa;   Drug: Epoetin beta;   Drug: Darbepoetin alfa
20 Recruiting FG-4592 (ASP1517) in the Treatment of Anemia in Chronic Kidney Disease Patients Not Requiring Dialysis
Condition: Anemia in Chronic Kidney Disease in Non-dialysis Patients
Interventions: Drug: FG-4592;   Drug: Placebo

Previous Page Studies Shown (1-20) Next Page (21-21) Show next page of results
Indicates status has not been verified in more than two years